The global Healthcare Patent Filing Outsourcing Market size is expected to reach USD 1.8 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.5% from 2021 to 2028. In-house departments of pharmaceutical and medical devices firms typically do not have sufficient time to carry out patent filing processes. Even if they do, it will be a costly option for the firms. Therefore, the market is significantly driven by the growing need for cost-saving and time-saving in patent filing processes.
The market suffered a hefty decline of 2.1% in 2020
owing to the COVID-19 pandemic. Organizations such as the European Patent
Office (EPO) and the United State Patent and Trademark Office (USPTO) announced
relaxations such as extension of deadlines in order to accommodate 2019 novel
coronavirus related delays and interruptions. However, with the lifting of
COVID-19 related shelter-in-place mandates and commercialization of the
vaccine, the bottle necking of patent filing is clearing. The market is
projected to recover from 2021 onwards and expand with a lucrative CAGR over
the forecast period.
Growing innovations in the medical device and
pharmaceutical space is driving the market. Surging number of start-ups in the
healthcare industry with new and innovative products, will also boost market
growth. Patent applications are majorly filed by the well-established players
in the healthcare industry such as Novartis, Covidien, Boston Scientific,
Medtronic, Ethicon, Olympus Corp. These companies innovate in-house, partner
with high-tech companies for consumer-facing offerings, and also license
technologies from universities. Such companies hold huge potential market
growth across the globe.
Related Press Release@ Healthcare Patent Filing Outsourcing Market Report
Healthcare Patent Filing
Outsourcing Market Report Highlights
- Medtech accounted for the largest revenue share of 51.2% in 2020
owing to growing technological innovations in medical devices
- Filing and prosecution services accounted for the largest revenue
share of over 50.0% in 2020 owing to complexity, cost-efficiency, and
time-saving associated with outsourcing such activities
- By origin, non-resident is the fastest growing segment with a CAGR of
5.9% between 2021 to 2028 as national patent in one country might not
prevent copying of a product or technology in a different country
- Asia pacific region contributed for the largest share of 65.5%
owing to high number of patents filed in the region coupled with
availability of low cost outsourcing services in the region. Furthermore,
the off-shore model is highly adopted in this industry, where such offices
are majorly placed in countries such as India, Japan, Korea, Malaysia,
Singapore and others
About Us:
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment